<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:mp ids='MP_0002055'>Diabetes</z:mp> is associated with increased risk of <z:hpo ids='HP_0000020'>urinary incontinence</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is unknown whether women with pre-<z:mp ids='MP_0002055'>diabetes</z:mp>, or impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (IFG), have increased prevalence of <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We determined the prevalence of, and risk factors for, <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> among U.S. women with <z:mp ids='MP_0002055'>diabetes</z:mp> and IFG </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: The 2001-2002 National Health and Nutrition Examination Survey measured fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and obtained information about <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000020'>urinary incontinence</z:hpo> among 1,461 nonpregnant adult women </plain></SENT>
<SENT sid="4" pm="."><plain>Self-reported weekly or more frequent <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e>, both overall and by type (<z:e sem="disease" ids="C0859070" disease_type="Disease or Syndrome" abbrv="">urge and stress</z:e>), was our outcome </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of the 1,461 women, 17% had <z:mp ids='MP_0002055'>diabetes</z:mp> and 11% met criteria for IFG </plain></SENT>
<SENT sid="6" pm="."><plain>Prevalence of weekly <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> was similar among women in these two groups (35.4 and 33.4%, respectively) and significantly higher than among women with <z:mpath ids='MPATH_458'>normal</z:mpath> fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (16.8%); both <z:e sem="disease" ids="C0859070" disease_type="Disease or Syndrome" abbrv="">urge and stress</z:e> <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> were increased </plain></SENT>
<SENT sid="7" pm="."><plain>In addition to well-recognized risk factors including age, weight, and oral <z:chebi fb="0" ids="50114">estrogen</z:chebi> use, two microvascular complications caused by <z:mp ids='MP_0002055'>diabetes</z:mp>, specifically macroalbuminuria and peripheral neuropathic pain, were associated with <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Physicians should be alert for <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e>, an often unrecognized and therefore undertreated disorder, among women with <z:mp ids='MP_0002055'>diabetes</z:mp> and IFG, in particular those with microvascular complications </plain></SENT>
<SENT sid="9" pm="."><plain>The additional prospect of improvements in their <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> may help motivate some high-risk women to undertake difficult lifestyle changes to reduce their more serious risk of <z:mp ids='MP_0002055'>diabetes</z:mp> and its sequelae </plain></SENT>
</text></document>